| Ytd | -12.99% | |
| 1y | -19.55% |
| Open | 39.38 | Prev Close | 39.10 | Low | 38.84 | High | 39.56 | Mkt Cap | 8.07B |
| Vol | 1.84M | Avg Vol | 2.26M | EPS | 1.96 | P/E | 19.96 | Forward P/E | 14.83 |
| Beta | 0.66 | Short Ratio | 3.51 | Inst. Own | 83.04% | Dividend | 0.35 | Div Yield | 0.88 |
| Ex Div Date | 07-07 | Earning | 08-04 | 50-d Avg | 36.15 | 200-d Avg | 43.65 | 1yr Est | 43.96 |
Morgan Stanley analyst Steve Beuchaw upgrades Qiagen (NYSE:QGEN) from Equal-Weight to Overweight
Planned gene expression assay launches and high-multiplex capabilities are expected to expand QIAcui